5-311332-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_013232.4(PDCD6):c.407G>A(p.Arg136Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000013 in 1,613,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013232.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PDCD6 | ENST00000264933.9 | c.407G>A | p.Arg136Gln | missense_variant | Exon 5 of 6 | 1 | NM_013232.4 | ENSP00000264933.4 | ||
ENSG00000286001 | ENST00000651543.1 | n.*1777G>A | non_coding_transcript_exon_variant | Exon 22 of 24 | ENSP00000499215.1 | |||||
ENSG00000286001 | ENST00000651543.1 | n.*1777G>A | 3_prime_UTR_variant | Exon 22 of 24 | ENSP00000499215.1 | |||||
PDCD6-AHRR | ENST00000675395.1 | n.208+7111G>A | intron_variant | Intron 3 of 13 | ENSP00000502570.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 250980Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135846
GnomAD4 exome AF: 0.0000130 AC: 19AN: 1461796Hom.: 0 Cov.: 29 AF XY: 0.00000963 AC XY: 7AN XY: 727210
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152130Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.407G>A (p.R136Q) alteration is located in exon 5 (coding exon 5) of the PDCD6 gene. This alteration results from a G to A substitution at nucleotide position 407, causing the arginine (R) at amino acid position 136 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at